First-Line Oral Analgesic Selection for Ankle Osteoarthritis
Ankle osteoarthritis requires careful selection of first-line oral analgesic therapy.
The appropriate agent depends on each patient's safety profile — particularly gastrointestinal risk
and any contraindications or intolerances that restrict which options are suitable.
Clinical Situation
This protocol addresses pharmacologic pain management in ankle osteoarthritis at the first treatment line.
Gastrointestinal risk and tolerability to oral analgesic classes are the key factors shaping the choice of agent and whether additional protective co-therapy is warranted.
Treatment Approach — partial overview
The protocol specifies an oral analgesic regimen that accounts for gastrointestinal safety,
with a defined alternative for patients who cannot receive the primary class of agent —
full agent selection criteria, co-therapy guidance, and dosing are contained in the complete protocol.
References
DOI: 10.1016/j.rdc.2022.03.009.
- Oral NSAIDs were generally recommended for all sites of OA, but strength of recommendations (conditional/weak versus strong) varied among guidelines, primarily reflecting concerns about adverse effects.
- Oral and topical NSAIDs are the pharmacologic agents most recommended for OA, though oral formulations should be avoided in those with contraindications and intolerances, and topical formulations are not appropriate for a deep joint such as the hip.
- Acetaminophen is no longer considered "first-line" for OA due to its relative poor efficacy, though it is still an option for those who have contraindications or intolerances to NSAIDs.
- Consider adding proton pump inhibitor or misoprostol in patients at risk for upper gastrointestinal events who require treatment with NSAIDs or COX-2 inhibitors.
View source ↗